node1	node2	edge_score	
DB00686	FGF4	1.0	
DB00686	FGF2	1.0	
DB00686	FGF1	1.0	
FGF2		1.0
Achondroplasia	FGF2	1.0	
Acquired Immunodeficiency Syndrome	FGF2	1.0	
 Adenocarcinoma, ovarian, somatic, 167000 (3)	FGF2	1.0	
Adenomas, multiple colorectal, 608456 (3)	FGF2	1.0	
Primary Myelofibrosis	FGF2	1.0	
AIDS Dementia Complex	FGF2	1.0	
Alzheimer Disease	FGF2	1.0	
Amyotrophic Lateral Sclerosis	FGF2	1.0	
Anaplasia	FGF2	1.0	
Anemia	FGF2	1.0	
{Aneurysm, familial abdominal 3} (2)	FGF2	1.0	
Arteriosclerosis	FGF2	1.0	
Arteriovenous malformation	FGF2	1.0	
Arthritis, Rheumatoid	FGF2	1.0	
Arthritis, Psoriatic	FGF2	1.0	
Rheumatoid arthritis	FGF2	1.0	
Asthma	FGF2	1.0	
Astrocytoma	FGF2	1.0	
Atherosclerosis	FGF2	1.0	
Melanoma, B16	FGF2	1.0	
Recurrent bacterial infection	FGF2	1.0	
Barrett Esophagus	FGF2	1.0	
Malignant tumor of urinary bladder	FGF2	1.0	
Urinary Bladder Neoplasms	FGF2	1.0	
Brain neoplasm	FGF2	1.0	
Breast-ovarian cancer, familial 1	FGF2	1.0	
Colon cancer	FGF2	1.0	
Malignant neoplasm of endometrium	FGF2	1.0	
Thyroid cancer, nonmedullary, 4	FGF2	1.0	
Non-small cell lung carcinoma	FGF2	1.0	
Renal cell carcinoma, nonpapillary	FGF2	1.0	
Squamous cell carcinoma	FGF2	1.0	
Urothelial Carcinoma	FGF2	1.0	
Intracranial Aneurysm	FGF2	1.0	
Ischaemic cerebral infarction	FGF2	1.0	
Malignant tumor of cervix	FGF2	1.0	
Cholesteatoma	FGF2	1.0	
Chondrosarcoma	FGF2	1.0	
Chordoma	FGF2	1.0	
Chorioamnionitis	FGF2	1.0	
Choriocarcinoma	FGF2	1.0	
Cleft Lip	FGF2	1.0	
Cleft Palate	FGF2	1.0	
Ulcerative colitis	FGF2	1.0	
Colorectal cancer 1	FGF2	1.0	
Colorectal Neoplasms	FGF2	1.0	
Verotoxigenic Escherichia coli gastrointestinal tract infection	FGF2	1.0	
Contractures involving the joints of the feet	FGF2	1.0	
Coronary heart disease 7	FGF2	1.0	
Craniosynostoses	FGF2	1.0	
Adenoid Cystic Carcinoma	FGF2	1.0	
{Unipolar depression, susceptibility to}, 608516 (3)	FGF2	1.0	
Depressive Disorder	FGF2	1.0	
Diabetes Mellitus, Type 1	FGF2	1.0	
Diabetes mellitus type 1	FGF2	1.0	
Diabetes mellitus type 2	FGF2	1.0	
Diabetic Angiopathies	FGF2	1.0	
Diabetic Nephropathies	FGF2	1.0	
Diabetic Retinopathy	FGF2	1.0	
Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	FGF2	1.0	
Experimental Autoimmune Encephalomyelitis	FGF2	1.0	
Endometriosis	FGF2	1.0	
Esophageal Neoplasms	FGF2	1.0	
Exostoses	FGF2	1.0	
Fetal Membranes, Premature Rupture	FGF2	1.0	
Fibrosarcoma	FGF2	1.0	
Fibrosis	FGF2	1.0	
Gastritis	FGF2	1.0	
Gastrointestinal Diseases	FGF2	1.0	
Glioblastoma	FGF2	1.0	
Glioma	FGF2	1.0	
Gliosis	FGF2	1.0	
Goiter, multinodular 1, with or without sertoli-leydig cell tumors	FGF2	1.0	
Head and Neck Neoplasms	FGF2	1.0	
Heart Diseases	FGF2	1.0	
Cardiomegaly	FGF2	1.0	
Heart Failure	FGF2	1.0	
Hemangioma	FGF2	1.0	
Diaphragmatic hernia	FGF2	1.0	
Herpes Simplex Infections	FGF2	1.0	
Symptomatic human immunodeficiency virus infection	FGF2	1.0	
Hodgkin Disease	FGF2	1.0	
Huntington's chorea	FGF2	1.0	
Hyperglycemia	FGF2	1.0	
Hyperplasia	FGF2	1.0	
Hypertension	FGF2	1.0	
Pulmonary hypertension, neonatal, susceptibility to	FGF2	1.0	
Inflammation	FGF2	1.0	
Inflammatory Bowel Diseases	FGF2	1.0	
Intermittent claudication	FGF2	1.0	
Ischemia	FGF2	1.0	
Arthropathy	FGF2	1.0	
Keloid	FGF2	1.0	
Kidney Diseases	FGF2	1.0	
Premature Obstetric Labor	FGF2	1.0	
Leiomyoma	FGF2	1.0	
Leukemia, Lymphocytic, Chronic, B-Cell	FGF2	1.0	
Chronic Lymphocytic Leukemia	FGF2	1.0	
Acute lymphoid leukemia	FGF2	1.0	
Acute myeloid leukemia	FGF2	1.0	
Chronic myeloid leukemia	FGF2	1.0	
Liver Cirrhosis, Biliary	FGF2	1.0	
Neoplasm of the liver	FGF2	1.0	
Chronic obstructive pulmonary disease	FGF2	1.0	
Lupus Erythematosus, Systemic	FGF2	1.0	
Lymphoma, Large B-Cell, Diffuse	FGF2	1.0	
Non-Hodgkin lymphoma	FGF2	1.0	
{Gastric cancer risk after H. pylori infection}, 137215 (3)	FGF2	1.0	
Animal Mammary Neoplasms	FGF2	1.0	
Marijuana Abuse	FGF2	1.0	
Medulloblastoma	FGF2	1.0	
Melanoma	FGF2	1.0	
Multiple Endocrine Neoplasia Type 1	FGF2	1.0	
Meningioma	FGF2	1.0	
Mesothelioma, malignant	FGF2	1.0	
Monoclonal Gammopathy of Undetermined Significance	FGF2	1.0	
Multiple Myeloma	FGF2	1.0	
Mycosis Fungoides	FGF2	1.0	
Myelofibrosis	FGF2	1.0	
Myeloproliferative Disorders	FGF2	1.0	
Myocardial Infarction	FGF2	1.0	
Epiphyseal dysplasia, multiple, with myopia and conductive deafness	FGF2	1.0	
Nasal polyposis	FGF2	1.0	
Secondary hypertriglyceridemia	FGF2	1.0	
Neoplasm Recurrence, Local	FGF2	1.0	
Multiple endocrine neoplasia, type 4	FGF2	1.0	
Pathologic Neovascularization	FGF2	1.0	
Nephritis	FGF2	1.0	
Tubulointerstitial nephritis	FGF2	1.0	
Nephrotic syndrome, type 5, with or without ocular abnormalities	FGF2	1.0	
Neurodegeneration with brain iron accumulation	FGF2	1.0	
Vestibular Schwannoma	FGF2	1.0	
Melanocytic nevus	FGF2	1.0	
Obesity	FGF2	1.0	
Oral Submucous Fibrosis	FGF2	1.0	
Osteoarthritis	FGF2	1.0	
Osteomalacia	FGF2	1.0	
Osteoporosis	FGF2	1.0	
Pancreatic Neoplasms	FGF2	1.0	
Pancytopenia	FGF2	1.0	
Parkinson Disease	FGF2	1.0	
Pituitary adenoma	FGF2	1.0	
Abnormality of the pituitary gland	FGF2	1.0	
Pituitary Neoplasms	FGF2	1.0	
Pleural effusion	FGF2	1.0	
Preeclampsia/eclampsia 1	FGF2	1.0	
Precancerous Conditions	FGF2	1.0	
Pregnancy in Diabetics	FGF2	1.0	
Prenatal Exposure Delayed Effects	FGF2	1.0	
Prolactinoma, familial	FGF2	1.0	
Prostatic Diseases	FGF2	1.0	
Prostatic Neoplasms	FGF2	1.0	
Psychoses, Substance-Induced	FGF2	1.0	
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4	FGF2	1.0	
Reperfusion Injury	FGF2	1.0	
Retinal degeneration	FGF2	1.0	
Retinopathy	FGF2	1.0	
Thrombosis of retinal vein	FGF2	1.0	
Retinoblastoma	FGF2	1.0	
Kaposi's sarcoma	FGF2	1.0	
Scleroderma	FGF2	1.0	
Scoliosis	FGF2	1.0	
Seizures, Febrile	FGF2	1.0	
Spinal cord compression	FGF2	1.0	
Gastric ulcer	FGF2	1.0	
Teratoma	FGF2	1.0	
Essential thrombocythemia	FGF2	1.0	
Thyroid Neoplasms	FGF2	1.0	
Peptic Ulcer Hemorrhage	FGF2	1.0	
Unipolar Depression	FGF2	1.0	
Uterine leiomyoma	FGF2	1.0	
Vascular Diseases	FGF2	1.0	
Virus Diseases	FGF2	1.0	
Vitiligo	FGF2	1.0	
B-cell lymphoma	FGF2	1.0	
Pleural Effusion, Malignant	FGF2	1.0	
Peripheral Arterial Disease	FGF2	1.0	
Corneal neovascularization	FGF2	1.0	
Severe combined immunodeficiency due to ADA deficiency	FGF2	1.0	
Neoplasms, Second Primary	FGF2	1.0	
Maternal diabetes	FGF2	1.0	
Small cell lung cancer	FGF2	1.0	
Dermal atrophy	FGF2	1.0	
Premature Birth	FGF2	1.0	
Acute myocardial ischemia	FGF2	1.0	
Cutaneous malignant melanoma 3	FGF2	1.0	
Adenocarcinoma of lung	FGF2	1.0	
Esophageal carcinoma	FGF2	1.0	
Primary pulmonary hypertension	FGF2	1.0	
Uterine Corpus Cancer	FGF2	1.0	
Malignant neoplasm of brain and nervous system	FGF2	1.0	
Secondary malignant neoplasm of lung	FGF2	1.0	
Proliferative diabetic retinopathy	FGF2	1.0	
Hearing Loss, Mixed Conductive-Sensorineural	FGF2	1.0	
Cleft palate with cleft lip	FGF2	1.0	
Tumor Progression	FGF2	1.0	
Embryonal Carcinoma	FGF2	1.0	
Thyroid cancer, follicular	FGF2	1.0	
Adrenocortical carcinoma	FGF2	1.0	
Cervical intraepithelial neoplasia (Cervical dysplasia)	FGF2	1.0	
Intraocular melanoma	FGF2	1.0	
Pancreatic Carcinoma	FGF2	1.0	
Cocaine-Related Disorders	FGF2	1.0	
Gastrointestinal stromal tumor	FGF2	1.0	
Papillary thyroid carcinoma	FGF2	1.0	
Hepatic fibrosis	FGF2	1.0	
Impotence	FGF2	1.0	
Malignant neoplasm of lung	FGF2	1.0	
Age-related macular degeneration 2	FGF2	1.0	
Disease Progression	FGF2	1.0	
Severe Myopia	FGF2	1.0	
Gastric Adenocarcinoma	FGF2	1.0	
Metastatic melanoma	FGF2	1.0	
Cancer of Head and Neck	FGF2	1.0	
Esophageal Squamous Cell Carcinoma	FGF2	1.0	
Adenocarcinoma Of Esophagus	FGF2	1.0	
Solid tumour	FGF2	1.0	
Carcinoma of cervix	FGF2	1.0	
Arteriovenous hemangioma	FGF2	1.0	
Anaplastic astrocytoma	FGF2	1.0	
Anaplastic Oligodendroglioma	FGF2	1.0	
Endometriosis of uterus	FGF2	1.0	
Malignant mesothelioma	FGF2	1.0	
Malignant neoplasm of pancreas	FGF2	1.0	
Malignant tumor of prostate	FGF2	1.0	
Hematopoietic Neoplasms	FGF2	1.0	
Idiopathic thrombocytopenic purpura	FGF2	1.0	
Endometrial carcinoma	FGF2	1.0	
Nevus	FGF2	1.0	
Recurrent tumor	FGF2	1.0	
Hepatitis C, Chronic	FGF2	1.0	
Mood Disorders	FGF2	1.0	
Malignant tumor of esophagus	FGF2	1.0	
Thyroid carcinoma	FGF2	1.0	
Ewing's sarcoma	FGF2	1.0	
Malignant Glioma	FGF2	1.0	
Osteosarcoma	FGF2	1.0	
Carcinogenesis	FGF2	1.0	
Leukemogenesis	FGF2	1.0	
Prostate carcinoma	FGF2	1.0	
Choroidal Neovascularization	FGF2	1.0	
Ovarian epithelial cancer	FGF2	1.0	
invasive cancer	FGF2	1.0	
Breast carcinoma	FGF2	1.0	
Lung cancer	FGF2	1.0	
Carcinoma of colon	FGF2	1.0	
Stomach cancer	FGF2	1.0	
Bladder carcinoma	FGF2	1.0	
Neuroblastoma	FGF2	1.0	
Middle Cerebral Artery Occlusion	FGF2	1.0	
Malignant neoplasm of kidney	FGF2	1.0	
Primary malignant neoplasm of brain	FGF2	1.0	
Well Differentiated Oligodendroglioma	FGF2	1.0	
Brain Infarction	FGF2	1.0	
Acute Cerebrovascular Accidents	FGF2	1.0	
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA	FGF2	1.0	
Endothelial dysfunction	FGF2	1.0	
Ovarian Neoplasms	FGF2	1.0	
Ischemic stroke	FGF2	1.0	
Ovarian adenocarcinoma	FGF2	1.0	
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	FGF2	1.0	
Endometrial adenocarcinoma	FGF2	1.0	
Squamous cell carcinoma of the head and neck	FGF2	1.0	
Sarcoma, Ewing	FGF2	1.0	
Major depressive disorder	FGF2	1.0	
Primary Effusion Lymphoma	FGF2	1.0	
B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	FGF2	1.0	
Cardiovascular morbidity	FGF2	1.0	
Adenoma of large intestine	FGF2	1.0	
Differentiated Thyroid Gland Carcinoma	FGF2	1.0	
Benign melanocytic nevus	FGF2	1.0	
Angiogenic Switch	FGF2	1.0	
Pleomorphic adenoma of salivary gland	FGF2	1.0	
Tumor-Associated Vasculature	FGF2	1.0	
Tumor Angiogenesis	FGF2	1.0	
Xenograft Model	FGF2	1.0	
Leukemia, Large Granular Lymphocytic	FGF2	1.0	
Colorectal cancer	FGF2	1.0	
Rash and Dermatitis Adverse Event Associated with Chemoradiation	FGF2	1.0	
Cystic Kidney Diseases	FGF2	1.0	
Benign Prostatic Hyperplasia	FGF2	1.0	
Idiopathic Pulmonary Fibrosis	FGF2	1.0	
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	FGF2	1.0	
Photoreceptor degeneration	FGF2	1.0	
Hepatocellular carcinoma	FGF2	1.0	
Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement	FGF2	1.0	
Limb ischemia	FGF2	1.0	
Pulmonary arterial hypertension	FGF2	1.0	
Secondary malignant neoplasm of pancreas	FGF2	1.0	
Familial X-linked hypophosphatemic vitamin D refractory rickets	FGF2	1.0	
Triple Negative Breast Neoplasms	FGF2	1.0	
Melanocytic nevus of skin	FGF2	1.0	
Experimental Organism Basal Cell Carcinoma	FGF2	1.0	
Interstitial fibrosis	FGF2	1.0	
